Business
Horizon Technology Finance Corporation Announces Offering of Common Stock
FARMINGTON, Conn., May 30, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") announced today a proposed
About this update from Horizon Technology Finance Corporation
[{"type":"text","content":"FARMINGTON, Conn., May 30, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) (the \"Company\" or \"Horizon\") announced today a proposed underwritten primary offering of 3,250,000 shares of its common stock. In connection with the proposed offering, the Company intends to grant the underwriters for the offering a 30-day option to purchase up to an additional 487,500 shares of the Company's common stock.\nThe joint-lead book-running managers for the offering are Morgan Stanley & Co. LLC, UBS Investment Bank, and Wells Fargo Securities.\nThe Company intends to use the net proceeds of this offering to repay its outstanding debt borrowed under its revolving credit facility provided by KeyBank National Association (the \"Key Facility\"). However, through re-borrowing of the initial repayments under its Key Facility, the Company intends to use the net proceeds from this offering to make investments in accordance with its investment objective and strategies described in the prospectus supplement and the accompanying prospectus, to pay the Company's operating expenses and other cash obligations, and for general corporate purposes.\nInvestors are advised to carefully consider the investment objective, risks, charges and expenses of the Company before investing. The preliminary prospectus supplement dated May 30, 2023 and the accompanying base prospectus dated July 21, 2021 contains this and other information about the Company and should be read carefully before investing. The information in the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may be changed.\nThe offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus, copies of which may be obtained from (1) Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, (2) UBS Investment Bank, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, New York 10019, Telephone: 888-827-7275, or by email at [email protected] or (3) Wells Fargo Securities, LLC at 550 West 33rd Street, New York, New York, 1001, Attn: Equity Syndicate Department, by calling toll free 1-800-326-5897, or by email at [email protected].\nThis press release does not constitute an offer to sell or the sol...